Heparosan Fermentation Purity via E. coli K5
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing heparin are contaminated with biological products, leading to safety issues and inefficiencies, particularly in the industrial scale-up of heparosan biosynthesis from E. coli K5, which requires optimized fermentation and purification conditions to achieve high yields and purity.
Innovation Solution
A method involving E. coli K5 fermentation in defined media with glucose as the primary carbon source, followed by a two-phase growth process, binding and elution of heparosan using solid phases, and subsequent purification steps to achieve high purity and yield, including the use of anionic exchange resins and chitosan for efficient recovery and depyrogenation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If heparin is prepared from animal tissues, then production capacity is sufficient (100 metric tons/year), but the product is contaminated with other biological products leading to safety issues
Solution Approach 1:
The patent extracts and isolates heparosan from E. coli K5 fermentation medium, separating it from other biological contaminants. The purification process uses precipitation with cold ethanol or isopropanol to selectively recover heparosan, achieving high purity (greater than 90%) while avoiding contamination issues associated with animal tissue sources
Solution Approach 2:
The patent uses anionic exchange resins as intermediaries to purify heparosan. The resins selectively bind heparosan from the fermentation medium, allowing separation from contaminants. This intermediary step enables high-purity recovery without direct contact with complex biological matrices
2Reliability
If E. coli K5 fermentation is used for heparosan production, then purity can be improved, but industrial scale-up requires optimized conditions to achieve high yields
Solution Approach 1:
The patent optimizes fermentation parameters including pH (maintained at 6.8-7.2), temperature (37°C), and dissolved oxygen (20-30% saturation) to maximize heparosan yield. The medium composition is specifically formulated with glucose (20g/L), thiamine (10-300mg/L), and various salts to enhance production. These parameter optimizations enable high yields suitable for industrial scale-up while maintaining purity
Solution Approach 2:
The patent employs fed-batch fermentation to maintain continuous production of heparosan. Glucose is fed continuously during the fermentation process to sustain high cell density and metabolic activity, ensuring continuous heparosan synthesis throughout the cultivation period rather than relying on batch-wise production
3Reliability
If complex purification steps are used to achieve high purity, then product quality improves, but process complexity and time increase
Solution Approach 1:
The patent performs preliminary concentration of heparosan from the fermentation medium by adjusting pH to 2.0-3.0 and adding cold ethanol or isopropanol to precipitate the polysaccharide. This preliminary step concentrates heparosan before anionic exchange chromatography, reducing the volume to be processed and simplifying subsequent purification steps while achieving greater than 90% purity
Solution Approach 2:
The purification process is segmented into distinct steps: (1) pH adjustment and cold alcohol precipitation for initial concentration and crude purification, (2) anionic exchange chromatography for polishing and final purification. This segmentation allows each step to be optimized independently and simplifies the overall process by breaking down the complex purification into manageable stages
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of high-purity heparosan with molecular weights suitable for processing into heparin, achieving yields in less than 60 hours with low contaminants, making it suitable for industrial production and pharmaceutical applications.
Implementation Method 1
E. coli K5 fermentation in defined media with glucose as the primary carbon source
Implementation Method 2
binding and elution of heparosan using solid phases, and subsequent purification steps
Implementation Method 3
including the use of anionic exchange resins and chitosan for efficient recovery
Data Source
AI summary
A method for the production of heparosan from fermentation culture of E. coli K5 suitable for industrial production, exhibiting superior yield and purity, smaller culture volumes, faster growth, and lower costs.